Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112687353 | 11268735 | 3 | F | 20150516 | 20160721 | 20150714 | 20160912 | PER | US-JNJFOC-20150705302 | JANSSEN | 69.30 | YR | E | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112687353 | 11268735 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 112687353 | 11268735 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 112687353 | 11268735 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 112687353 | 11268735 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 112687353 | 11268735 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 112687353 | 11268735 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 202439 | 20 | MG | TABLET | QD | |||||
| 112687353 | 11268735 | 7 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | 0 | 6 | MG | UNSPECIFIED | |||||||
| 112687353 | 11268735 | 8 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 112687353 | 11268735 | 9 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | TABLET | ||||||||
| 112687353 | 11268735 | 10 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 112687353 | 11268735 | 11 | C | OXYCODONE | OXYCODONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 112687353 | 11268735 | 12 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 200 MCG | 0 | UNSPECIFIED | |||||||||
| 112687353 | 11268735 | 13 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112687353 | 11268735 | 1 | Atrial fibrillation |
| 112687353 | 11268735 | 2 | Atrial fibrillation |
| 112687353 | 11268735 | 3 | Thrombosis prophylaxis |
| 112687353 | 11268735 | 4 | Thrombosis prophylaxis |
| 112687353 | 11268735 | 5 | Cerebrovascular accident prophylaxis |
| 112687353 | 11268735 | 6 | Cerebrovascular accident prophylaxis |
| 112687353 | 11268735 | 7 | Atrial fibrillation |
| 112687353 | 11268735 | 8 | Stent placement |
| 112687353 | 11268735 | 9 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112687353 | 11268735 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112687353 | 11268735 | Haemorrhoidal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112687353 | 11268735 | 1 | 20140701 | 20150516 | 0 | |
| 112687353 | 11268735 | 2 | 2015 | 20150721 | 0 | |
| 112687353 | 11268735 | 3 | 2015 | 20150721 | 0 | |
| 112687353 | 11268735 | 4 | 20140701 | 20150516 | 0 | |
| 112687353 | 11268735 | 5 | 2015 | 20150721 | 0 | |
| 112687353 | 11268735 | 6 | 20140701 | 20150516 | 0 | |
| 112687353 | 11268735 | 7 | 2015 | 0 | ||
| 112687353 | 11268735 | 9 | 201505 | 0 | ||
| 112687353 | 11268735 | 10 | 201605 | 0 | ||
| 112687353 | 11268735 | 11 | 2011 | 0 |